Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Azzak

<< Previous

Bullboard Posts

Next >>

Post by pelabooston Nov 14, 2023 3:18pm

187 Views

Post# 35735174

Azzak

I really do not like this SH format. Very sad.

I am in no way suggesting PanCAN was disavowing the science. I believe they are on board and will bring great strength to the trials. I was merely wondering, if, as a charity they would feel more comfortable not being too close to this type of money. I admit I am likely off base on that. However I am not comfortable with this money. It begs too manyquestions.

Nevertheless, onward and upward.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia